DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Short Term Loans and Advances History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Short Term Loans and Advances | ₹794 Cr | ₹715 Cr | ₹1,509 Cr | ₹761 Cr | ₹1,150 Cr |
What is the latest Short Term Loans and Advances ratio of DIVIS LABORATORIES ?
Year | Short Term Loans and Advances |
---|---|
Mar2024 | ₹794 Cr |
Mar2023 | ₹715 Cr |
Mar2022 | ₹1,509 Cr |
Mar2021 | ₹761 Cr |
Mar2020 | ₹1,150 Cr |
How is Short Term Loans and Advances of DIVIS LABORATORIES Trending?
Years | Short Term Loans and Advances | % Change | |
---|---|---|---|
Mar2024 | ₹794 Cr | 11.05 | |
Mar2023 | ₹715 Cr | -52.63 | |
Mar2022 | ₹1,509 Cr | 98.37 | |
Mar2021 | ₹761 Cr | -33.85 | |
Mar2020 | ₹1,150 Cr | - |
Compare Short Term Loans and Advances of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹177,593.0 Cr | 0.3% | 6.5% | 49% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹404,420.0 Cr | -0.2% | -2.9% | 12.6% | Stock Analytics | |
CIPLA | ₹123,329.0 Cr | 1.1% | 1.8% | -1.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,396.0 Cr | -0.2% | 9.5% | 12.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,956.0 Cr | 1.9% | 0.4% | 14% | Stock Analytics | |
MANKIND PHARMA | ₹97,734.2 Cr | -0.4% | -7.8% | 9.9% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | 0.3% |
6.5% |
49% |
SENSEX | -0.8% |
-0.9% |
6.9% |
You may also like the below Video Courses